Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 3.3B | 8.6B | 9.9B | 8.7B |
Cost of revenue | 2.6B | 6.4B | 7.4B | 6.8B |
Gross profit | 696.7M | 2.1B | 2.5B | 1.9B |
Operating expense | ||||
Research & development | — | 442.0M | 337.9M | 396.5M |
Selling general and admin | 1.5B | 357.1M | 235.3M | 230.8M |
Other operating expenses | — | -73.3M | 129.5M | 32.0M |
Operating income | 696.7M | 576.2M | 988.1M | 556.3M |
Non operating interest income | ||||
Income | — | 24.9M | 85.5M | 71.3M |
Expense | — | 39.7M | 107.2M | 42.0M |
Other income expense | — | — | — | — |
Pretax income | -373.9M | 384.3M | 1.2B | 171.6M |
Tax provision | — | 56.9M | 29.6M | -39.3M |
Net income | -373.9M | 327.4M | 1.2B | 210.9M |
Basic EPS | -45.3 | — | 147 | 28 |
Diluted EPS | -45.3 | — | 147 | 28 |
Basic average shares | — | — | 8.1M | 7.8M |
Diluted average shares | — | — | 8.1M | 7.8M |
EBITDA | 696.7M | 1.6B | 1.2B | 1.2B |
Net income from continuing op. | — | 327.4M | 1.2B | 210.9M |
Minority interests | 16.2M | 15.7M | 29.3M | 8.3M |
Preferred stock dividends | — | — | — | — |